Anticorps Recombinant de lapin anti-Phospho-IkB Beta (Thr19/Ser23)

Phospho-IkB Beta (Thr19/Ser23) Recombinant Antibody for WB, FC (Intra), ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain et plus (1)

Applications

WB, FC (Intra), ELISA

Conjugaison

Non conjugué

Publications(1)

CloneNo.

241061B2

N° de cat : 84403-1-RR

Synonymes

IkB beta, IκB beta, IκB β, NFKBIB, IkB B



Applications testées

Résultats positifs en WBTNF alpha and Calyculin A treated HT-29 cells,
Résultats positifs en FC (Intra)TNF alpha and Calyculin A treated HT-29 cells,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:10000
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Applications publiées

WBSee 1 publications below

Informations sur le produit

84403-1-RR cible Phospho-IkB Beta (Thr19/Ser23) dans les applications de WB, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Réactivité citéerat
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Peptide
Nom complet nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
Masse moléculaire calculée 356 aa, 38 kDa
Poids moléculaire observé 50 kDa
Numéro d’acquisition GenBankBC015528
Symbole du gène IkB Beta
Identification du gène (NCBI) 4793
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

IkB Beta is also named as NF-kappa-B inhibitor beta (NFKBIB) and TRIP-9. IKBB is one of the major isoforms of the NFKB inhibitor which preferentially interacts with c-Rel or p65 NF-kB dimers (PMID: 26227166). IKBB was reported to be associated with tumor growth inhibition and metastasis in lung cancer (PMID: 11402320). IKBB also inhibits cancer cell regulation through inactivation of the NFkB pathway (PMID: 18950638). Exposure of cells to a variety of extracellular stimuli leads to the rapid phosphorylation, ubiquitination, and ultimately proteolytic degradation of IkB, which frees NF-kB to translocate to the nucleus where it regulates gene transcription (PMID: 10837071). The antibody is phosphorylated at Thr19 and Ser23.

Protocole

Product Specific Protocols
WB protocol for Phospho-IkB Beta (Thr19/Ser23) antibody 84403-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
ratWB

ACS Appl Mater Interfaces

Cerium-Organic Framework and Resveratrol Composite Hydrogel Scaffold with Dual Antioxidant Activity for Enhanced Bone Regeneration

Authors - Yao Lu
{{ptg:RelatedPrimaryAntibodies}}